Medical cannabis sales in Utah increased by 59% between 2021 and 2022, according to data published by the Utah Department of Health & Human Services’ Center for Medical Cannabis.
Net medical cannabis sales for 2022 totaled $118.7 million, compared to $74.8 million in 2021, according to data published by the center.
January 2023 net sales were worth $10.9 million, with the Center for Medical Cannabis reporting 63,622 registered patients that month.
Persistent pain was the most common qualifying medical condition, followed by post-traumatic stress disorder.
The number of active registered patients in Utah grew by 51% between Oct. 1, 2021, and Sept. 30, 2022, according to the Center for Medical Cannabis’ 2022 annual report, which was issued in November.
Utah’s 2022 net sales total is in line with projections from the 2022 MJBiz Factbook, which forecast 2022 sales of between $105 million and $130 million.
Read full article on Marijuana Business Daily